Marc A. Becker, Ph.D.
Affiliations: | 2010 | Pharmacology | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Molecular BiologyGoogle:
"Marc Becker"Parents
Sign in to add mentor| Douglas Yee | grad student | 2010 | UMN | |
| (The IGF pathway regulates steroid receptor crosstalk and global gene expression in breast cancer cells through an IRS-dependent mechanism.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| DeJong S, Hou X, Zanfagnin V, et al. (2020) Gemcitabine and novel Chk1 inhibitor GDC-0575 demonstrate synergistic effect against high-grade serous ovarian cancer in 3D cell culture, PDX models and patient tumors Gynecologic Oncology. 159: 90 |
| Kurokawa C, Iankov ID, Anderson SK, et al. (2018) Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy. Journal of the National Cancer Institute |
| Butler KA, Hou X, Becker MA, et al. (2017) Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts. Neoplasia (New York, N.Y.). 19: 628-636 |
| Zanfagnin V, Bale LK, Becker MA, et al. (2017) Abstract 4817: Regression of malignant ascites via PAPP-A inhibition in ovarian cancer patient-derived xenograft model Cancer Research. 77: 4817-4817 |
| Becker MA, Hou X, Tienchaianada P, et al. (2016) Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer. Bmc Cancer. 16: 814 |
| AlHilli MM, Becker MA, Weroha SJ, et al. (2016) In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma. Gynecologic Oncology |
| Martchenko K, Schmidtmann I, Thomaidis T, et al. (2016) Last line therapy with sorafenib in colorectal cancer: A retrospective analysis. World Journal of Gastroenterology. 22: 5400-5 |
| Becker MA, Ibrahim YH, Oh AS, et al. (2016) Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer. Plos One. 11: e0150564 |
| Long B, Hou X, Becker M, et al. (2016) MC1463: Avatar-directed chemotherapy in platinum-resistant ovarian cancer. Journal of Clinical Oncology. 34 |
| Harris FR, Halling GC, Becker MA, et al. (2016) Abstract 13: Individualized approach for ovarian cancer: Identification of potential therapeutic targets based on genomic analyses, testing efficiency of treatments, and monitoring Clinical Cancer Research. 22: 13-13 |